Related Experiment Video
Updated: Jun 22, 2026
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Endothelial cells facilitate cell-based cardiac repair: progress and challenge
1Stem cell and functional genomics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China. pyuan@cuhk.edu.hk.
Insights
Heart damage from myocardial infarction is significant, with limited natural regeneration. Endothelial cell-facilitated stem cell therapy shows promise for improved heart repair, though clinical application challenges remain.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Cell Therapy
Background:
- Myocardial infarction causes substantial cardiomyocyte loss (approx. 1 billion cells).
- The heart possesses extremely limited natural cardiomyocyte regeneration capacity.
- Previous cell therapies for heart repair have encountered various limitations.
Purpose of the Study:
- To review progress in cell-based heart repair strategies.
- To emphasize endothelial cell-facilitated stem cell therapy.
- To summarize endothelial cell mechanisms in cardiac repair.
Main Methods:
- Literature review of studies on cell transplantation for heart repair.
- Focus on research combining stem cells and endothelial cells.
- Analysis of endothelial cell roles and clinical translation challenges.
Main Results:
- Concomitant transplantation of endothelial cells and stem cells enhances heart repair efficacy.
- Endothelial cells offer beneficial mechanisms supporting cardiac repair.
- Potential challenges for clinical adoption of this therapy are identified.
Conclusions:
- Endothelial cell-facilitated stem cell therapy represents a promising advancement in cardiac regenerative medicine.
- Further research is needed to overcome challenges for clinical application.
- This approach holds potential for treating heart disease and improving patient outcomes.
Abstract:
About 1 billion cardiomyocytes are lost in heart disease such as myocardial infarction; the regeneration capacity of cardiomyocytes is extremely low and the heart is unable to fix this damage naturally. In the past 20 years, multiple cells, such as skeletal myoblasts, bone marrow-derived cells, cardiac progenitor cells and pluripotent stem cells have been utilized to test the efficacy on heart repair, but these cells show different kinds of drawbacks. Recent studies have revealed that concomitant transplantation of endothelial cells and stem cells can significantly improve the efficacy of cell based heart repair. In this review, we describe the progress on these studies with an emphasis on endothelial cell facilitated stem cell therapy. We also summarize the beneficial mechanisms of endothelial cells in cardiac repair and point out the potential challenges for endothelial cell-facilitated-cell therapy to be adopted for clinical application.
